Differences in heart failure with preserved ejection fraction management between care providers: an international survey

Federica Guidetti,Clara Inés Saldarriaga Giraldo,Anastasia Shchendrygina,Keisuke Kida,David Niederseer,Carmen Basic,Peter P. Rainer,Marta Załęska‐Kocięcka,Elijah Ogola,Dania Mohty,Giuseppina Lanfranchi,Novi Yanti Sari,Hafsteinn Einarsson,Marzena Zurek,Frank Ruschitzka,Gianluigi Savarese,Nathan Mewton

DOI: https://doi.org/10.1002/ejhf.3416

2024-08-23

European Journal of Heart Failure

Abstract:Differences in heart failure with preserved ejection fraction (HFpEF) management across medical specialties. ACE‐i, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; BB, beta blocker; MRA, mineralocorticoid receptor antagonist; SGLT2i, sodium–glucose cotransporter 2 inhibitors Aims Heart failure (HF) with preserved ejection fraction (HFpEF) is characterized by growing incidence and poor outcomes. A large majority of HFpEF patients are cared by non‐cardiologists. The availability of sodium–glucose cotransporter 2 inhibitors (SGLT2i) as recommended therapy raises the importance of prompt and accurate identification and treatment of HFpEF across diverse healthcare settings. We evaluated HFpEF management across specialties through a survey targeting cardiologists, HF specialists, and non‐cardiologists. Methods and results An independent web‐based survey was distributed globally between May and July 2023. We performed a post‐hoc analysis, comparing cardiologists, HF specialists, and non‐cardiologists. A total of 1460 physicians (61% male, median age 41[34–49]) from 95 countries completed the survey; 20% were HF specialists, 65% cardiologists, and 15% non‐cardiologists. Compared with HF specialists, non‐cardiologists and cardiologists were less likely to use natriuretic peptides (p = 0.003) and HFpEF scores (p = 0.004) for diagnosis, and were also less likely to have access to or consider specific echocardiographic parameters (p

cardiac & cardiovascular systems